A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients

Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially dose-limiting side-effect of neurotoxic chemotherapy for cancer patients. We evaluated the preliminary efficacy of acupuncture in preventing worsening CIPN in patients receiving paclitaxel.

Source: European Journal of Cancer - July 12, 2018 Category: Cancer & Oncology Authors: Ting Bao, Andrew D. Seidman, Lauren Piulson, Emily Vertosick, Xi Chen, Andrew J. Vickers, Victoria S. Blinder, Wanqing I. Zhi, Qing Li, Linda T. Vahdat, Maura N. Dickler, Mark E. Robson, Jun J. Mao Tags: Original Research Source Type: research